July 3-9
A July 7 story,
Once-Failed Hepatitis Drug Has Some Saying SciClone is Full of Hot Air, omitted to mention that
Schering-Plough
(SGP:NYSE) is testing
SciClone's
(SCLN:Nasdaq) hepatitis drug,
Zadaxin
, in Japan. (
corrected July 7
)
Because of an editing error, a July 6 story,
Gap, Ross Expect to Fall Short of Earnings Forecast, mistakenly reported that
Gap
(GPS:NYSE) shares dropped 3 1/2 points Thursday. In fact, the stock rose 3 1/2, or 12%, to close at 33 3/8. (
corrected July 7
TheStreet Recommends
)
A July 5 story,
Market Starting to See the Bad Side of a Slowdown, incorrectly stated that
EMC
(EMC:NYSE) had issued an earnings warning in June. In fact,
EDS
(EDS:NYSE) issued the warning.
(corrected July 6)
A July 3 story,
Island ECN Converts to Pricing Stocks in Decimals, incorrectly identified the number of trades handled by
Datek Online Holdings
as being those handled by
Island ECN
. The story should have noted that Datek has averaged around 100,000 trades a day in recent weeks and had recorded some 22,000 trades by midmorning Monday.(
corrected July 5
)
